Yüklüyor......

Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil

Heart failure continues to be a major global health problem with a pronounced impact on morbidity and mortality and very limited drug treatment options especially with regard to inotropic therapy. Omecamtiv mecarbil is a first-in-class cardiac myosin activator, which increases the proportion of myos...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drugs Context
Asıl Yazarlar: Kaplinsky, Edgardo, Mallarkey, Gordon
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioExcel Publishing Ltd 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5916097/
https://ncbi.nlm.nih.gov/pubmed/29707029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212518
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!